Form 4 Tracker
Corvus Pharmaceuticals, Inc.
CRVS

8 insider filings · Latest: Jun 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 11, 2026Jun 15 9:12 PMDavid Scott MooreDirector
Purchase
21,700$11.53$250.2K21,700(D)

View →

May 18, 2026May 20 8:12 PMRichard A Miller MDDirector, President and CEO
Purchase
6,932$12.04$83.5K1,195,035(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 11, 2026Jun 15 9:12 PMDavid Scott MooreDirector
Grant/Award
15,000$11.6015,000(D)

View →

Jun 11, 2026Jun 15 9:10 PMIan T ClarkDirector
Grant/Award
15,000$11.6015,000(D)

View →

Jun 11, 2026Jun 15 9:08 PMLinda GraisDirector
Grant/Award
15,000$11.6015,000(D)

View →

Jun 11, 2026Jun 15 9:06 PMPeter A. ThompsonDirector, 10% Owner
Grant/Award
15,000$11.6015,000(D)

View →

Jun 11, 2026Jun 15 9:04 PMDen Broek Richard VanDirector
Grant/Award
15,000$11.6015,000(D)

View →

Apr 23, 2026Apr 27 9:32 PMAndrew C. ChanDirector
Grant/Award
30,000$16.0230,000(D)

View →

Jan 28, 2026Jan 30 11:39 PMPeter A. ThompsonDirector, 10% Owner
Option Exercise
210,000$15.000(D)

View →